ID
45573
Beschrijving
Principal Investigator: Rameen Beroukhim, MD, PhD, Dana-Farber Cancer Institute, Boston, MA 02215, USA MeSH: Meningioma https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000552 Meningiomas are the most common primary brain tumor in the US. Although the tumor suppressor gene NF2 is disrupted in approximately half of meningiomas, the complete spectrum of genetic changes in meningiomas remains poorly understood, particularly in the large subset of tumors without NF2 alterations. Therefore we performed whole-genome sequencing from 11 Grade I meningioma tumor-normal pairs and whole-exome sequencing from an additional 6 tumor-normal pairs to identify somatic mutations, insertions-deletions, copy-number alterations and rearrangements. We validated our results by performing focused sequencing across 48 additional meningiomas.
Link
Trefwoorden
Versies (1)
- 24-01-23 24-01-23 - Dr. Christian Niklas
Houder van rechten
Rameen Beroukhim, MD, PhD, Dana-Farber Cancer Institute, Boston, MA 02215, USA
Geüploaded op
24 januari 2023
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
dbGaP phs000552 Genomic Characterization of Meningiomas
Eligibility Criteria
- StudyEvent: SEV1
- Eligibility Criteria
- Subject ID and consent group of participants with meningioma and involved in the "Genomic Characterization of Meningiomas" project.
- Sample ID, subject ID, and sample use variables obtained from participants with meningioma and involved in the "Genomic Characterization of Meningiomas" project.
- Subject ID, age, and sex of participants with meningioma and involved in the "Genomic Characterization of Meningiomas" project.
- Sample ID, body site where sample was collected, analyte type of samples, tumor status, histological type of samples, and whether the sample was obtained from recurrent tumor associated with participants with meningioma and involved in the "Genomic Characterization of Meningiomas" project.
Similar models
Eligibility Criteria
- StudyEvent: SEV1
- Eligibility Criteria
- Subject ID and consent group of participants with meningioma and involved in the "Genomic Characterization of Meningiomas" project.
- Sample ID, subject ID, and sample use variables obtained from participants with meningioma and involved in the "Genomic Characterization of Meningiomas" project.
- Subject ID, age, and sex of participants with meningioma and involved in the "Genomic Characterization of Meningiomas" project.
- Sample ID, body site where sample was collected, analyte type of samples, tumor status, histological type of samples, and whether the sample was obtained from recurrent tumor associated with participants with meningioma and involved in the "Genomic Characterization of Meningiomas" project.
C0680251 (UMLS CUI [1,2])
C0428093 (UMLS CUI [1,2])